KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
15,250
+170 (1.13%)
Last updated: Jul 10, 2025
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 165.13 billion as of July 11, 2025. Its market cap has decreased by -21.15% in one year.
Market Cap
165.13B
Enterprise Value
153.61B
Revenue
81.78B
Ranking
n/a
PE Ratio
55.26
Stock Price
15,250.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 165.13B, a decrease of -10.15%. That is a compound annual growth rate of -2.15%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 11, 2025 | 165.13B | -1.11% |
Dec 30, 2024 | 166.98B | -35.26% |
Dec 28, 2023 | 257.94B | 10.51% |
Dec 29, 2022 | 233.40B | -55.92% |
Dec 30, 2021 | 529.52B | 118.69% |
Dec 30, 2020 | 242.13B | 31.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 399.60T |
SK hynix | 205.03T |
Samsung Biologics | 76.87T |
LG Energy Solution | 74.41T |
Hyundai Motor Company | 45.43T |
KB Financial Group | 42.53T |
Doosan Enerbility | 40.41T |
Hanwha Aerospace | 40.25T |